REQUEST A DEMO
Total
USD $0.00
Search more companies

Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) (China)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Tianjin Chase Sun Pharmaceutical Co., Ltd Profile Updated: March 01, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Chinese Download a sample report

Tianjin Chase Sun Pharmaceutical Co.,Ltd is a pharmaceutical company specializing in the development of new medical clinical services and the promotion of Chinese Medical Traditional Education Platform. The company is involved in the research and development of drugs for serious diseases, anti-tumor, cardiovascular, respiratory system, and neurodegenerative drugs. It operates a subsidiary, Hainan Loong Sanctuary Medicine, which produces drugs for lung cancer and digestive system tumors. The company has a focus on the Chinese medical industry.

Headquarters
Building B01, Entrepreneurship Headquarters Base, Wuqing Development Zone, Tianjin
Tianjin; Tianjin; Postal Code: 301700

Contact Details: Purchase the Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) report to view the information.

Website: http://www.chasesun.cn

Basic Information
Total Employees:
Purchase the Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) report to view the information.
Outstanding Shares:
Purchase the Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) report to view the information.
Registered Capital:
Purchase the Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) report to view the information.
Financial Auditors:
Purchase the Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) report to view the information.
Incorporation Date:
September 23, 1996
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
General Manager
Purchase this report to view the information.
Deputy General Manager
Ownership Details
Purchase this report to view the information.
22.24%
Purchase this report to view the information.
10%
Purchase this report to view the information.
3.81%
Purchase this report to view the information.
2.26%
Purchase this report to view the information.
1.13%
Subsidiaries
American Supers, LLC
100%
Australia Red Sun Limited
100%
Beijing Chaosi Electronic Technology Co., Ltd.
100%
Company Performance
Financial values in the chart are available after Tianjin Chase Sun Pharmaceutical Co., Ltd (天津红日药业股份有限公司) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CNY. Absolute financial data is included in the purchased report.
Net sales revenue
-6.59%
Total operating revenue
-6.63%
Operating Profit/Loss (EBIT)
-18.32%
Net Profit/Loss for the Period
-52.22%
Total Assets
-5.39%
Total Equity
-1.84%
Operating Profit Margin (ROS)
-0.57%
Net Profit Margin
-2.11%
Return on Equity (ROE)
-1.11%
Debt/Equity
-1.78%
Quick Ratio
0.63%
Cash Ratio
0.35%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?